Àwọn nǹkan bíi mélòó kan wà tó lè fa àrùn àtọ̀gbẹ, títí kan:
1. Ìtàn ìdílé: Tó o bá ní òbí tàbí arákùnrin tàbí arábìnrin tó ní àrùn àtọ̀gbẹ, ó máa ń mú kí ewu náà pọ̀ sí i.
2. Ọ̀dọ́mọdé: Bí èèyàn bá ṣe ń dàgbà sí i, pàápàá lẹ́yìn tó ti pé ọmọ ọdún ogójì, ewu tó wà láti ní àrùn àtọ̀gbẹ oríṣi kejì máa ń pọ̀ sí i.
3. Ìwọ̀n: Tó o bá sanra ju bó ṣe yẹ lọ tàbí tó o bá sanra ju bó ṣe yẹ lọ, ó máa ń mú kí ewu náà pọ̀ sí i.
4. Àìṣe eré ìmárale: Àìṣe eré ìmárale lè mú kí ewu náà pọ̀ sí i.
5. Ìran tàbí ẹ̀yà: Àwọn ẹ̀yà kan, irú bí àwọn ọmọ ilẹ̀ Áfíríkà, àwọn ọmọ ilẹ̀ Hispanic, àwọn ọmọ ilẹ̀ Amẹ́ríkà, àti àwọn ọmọ ilẹ̀ Éṣíà ní ewu tó ga jù lọ láti ní àrùn àtọ̀gbẹ oríṣi kejì.
6. Àrùn àtọ̀gbẹ nígbà oyún: Àwọn obìnrin tó ní àrùn àtọ̀gbẹ nígbà oyún ní ewu tó ga jù lọ láti ní àrùn àtọ̀gbẹ oríṣi kejì nígbà tó bá yá.
7. Polycystic ovary syndrome: Àwọn obìnrin tó ní àìsàn yìí ní ewu tó ga jù lọ láti ní àrùn àtọ̀gbẹ oríṣi kejì.
8. Àrùn Metabolic syndrome: Àrùn yìí, tó ní í ṣe pẹ̀lú ẹ̀jẹ̀ rírẹlẹ̀, èròjà cholesterol tó pọ̀ gan-an, àti àlàfo tó pọ̀ gan-an, máa ń mú kí àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
9. Fífi sìgá mu: Fífi sìgá mu lè mú kí ẹ̀jẹ̀ èèyàn túbọ̀ máa gbógun ti èròjà insulin, èyí sì lè yọrí sí àrùn àtọ̀gbẹ oríṣi kejì.
10. Àrùn àtọ̀gbẹ: Tó o bá ní àrùn àtọ̀gbẹ, tàbí tó o bá ní ìwọ̀n ṣúgà nínú ẹ̀jẹ̀ tó ga ju bó ṣe yẹ lọ, ó lè mú kó o ní àrùn àtọ̀gbẹ oríṣi kejì.
11. Ìwọ̀n ọmọ tó kéré nígbà tí wọ́n bí i: Àwọn ọmọ tó kéré nígbà tí wọ́n bí i ní ewu tó pọ̀ jù láti ní àrùn àtọ̀gbẹ orí kejì nígbà tó bá dàgbà.
12. Ìrísí ẹ̀jẹ̀ tó ga: Ìrísí ẹ̀jẹ̀ tó ga máa ń mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
13. Ìwọ̀n cholesterol àti triglyceride tí kò bófin mu: Ìwọ̀n triglyceride tó ga àti ìwọ̀n HDL (ìwọ̀n cholesterol tó dára) tó kéré máa ń mú kí àrùn àtọ̀gbẹ oríṣi kejì wáyé.
14. Àrùn apnea oorun: Àwọn tó ní àrùn apnea oorun máa ń ní àrùn àtọ̀gbẹ oríṣi kejì.
15. Ìrora ọkàn: Ìrora ọkàn tó máa ń báni fínra lè mú kí àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
16. Àwọn oògùn kan: Àwọn oògùn kan, irú bí àwọn oògùn tí wọ́n ń pè ní steroid àti àwọn oògùn tí wọ́n ń pè ní antipsychotic, lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
17. Àrùn: Àrùn tí kì í pẹ́ lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
Ìgbésí ayé tí kò fi bẹ́ẹ̀ rìn: Ìgbésí ayé tí kò fi bẹ́ẹ̀ rìn lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
19. Oúnjẹ tó ní èròjà ọ̀gẹ̀dẹ̀ tó pọ̀ gan-an: Oúnjẹ tó ní èròjà ọ̀gẹ̀dẹ̀ tó pọ̀ gan-an tó sì ní èròjà ọ̀gẹ̀dẹ̀ tó pọ̀ gan-an lè mú kí àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
20. Ọtí líle: Ọtí líle tó pọ̀ ju bó ṣe yẹ lọ lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
21. Àìsí oorun: Àìsí oorun tó péye lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
22. Ìbàjẹ́ afẹ́fẹ́: Ìbàjẹ́ afẹ́fẹ́ lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
23. Àwọn kòkòrò àrùn kan: Àwọn kòkòrò àrùn kan, irú bí àrùn hepatitis C, lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
24. Ìwọ̀n homocysteine tó pọ̀ gan-an: Ìwọ̀n homocysteine tó pọ̀ gan-an, tó jẹ́ èròjà amino acid, lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
25. Ìwọ̀n tó pọ̀ gan-an nínú èròjà uric acid: Ìwọ̀n tó pọ̀ gan-an nínú èròjà uric acid, tó jẹ́ èròjà tí wọ́n máa ń mú jáde, lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
26. Àwọn èròjà protein C-reactive tó pọ̀ gan-an: Àwọn èròjà protein C-reactive tó pọ̀ gan-an, tó jẹ́ àmì ìdààmú ara, lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
27. Ìwọ̀n fibrinogen tó pọ̀ gan-an: Ìwọ̀n fibrinogen tó pọ̀ gan-an, tó jẹ́ èròjà protein tó ń mú kí ẹ̀jẹ̀ máa yọ́, lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
28. Àwọn èròjà PAI-1 tó pọ̀ gan-an: Àwọn èròjà PAI-1 tó pọ̀ gan-an, èyí tó jẹ́ èròjà protein tó ń mú kí ẹ̀jẹ̀ máa dà pọ̀, lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
29. Ìwọ̀n tó pọ̀ gan-an nínú èròjà leptin: Ìwọ̀n tó pọ̀ gan-an nínú èròjà leptin, tó jẹ́ èròjà tó ń darí ìfẹ́ oúnjẹ, lè mú kí ewu àrùn àtọ̀gbẹ oríṣi kejì pọ̀ sí i.
30. Iwọn giga ti resistin: Iwọn giga ti resistin, homonu ti o ni ipa ninu resistance insulin, le mu eewu ti idagbasoke
King WM, Saseen JJ, Anderson SL: Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014, 5 (5): 206-11.
Bielinski SJ, Pankow JS, Rasmussen-Torvik LJ, Bailey K, Li M, Selvin E, Couper D, Vazquez G, Brancati F: Strength of association for incident diabetes risk factors according to diabetes case definitions: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012, 175 (5): 466-72.
Gangwisch JE, Gross R, Malaspina D: Differential Associations Between Depression, Risk Factors for Insulin Resistance and Diabetes Incidence in a Large U.S. Sample. Isr J Psychiatry Relat Sci. 2015, 52 (2): 85-90.
Leiva AM, Martínez MA, Petermann F, Garrido-Méndez A, Poblete-Valderrama F, Díaz-Martínez X, Celis-Morales C: [Risk factors associated with type 2 diabetes in Chile]. Nutr Hosp. 2018, 35 (2): 400-407.
Chatterjee R, Maruthur NM, Edelman D: Novel Risk Factors for Type 2 Diabetes in African-Americans. Curr Diab Rep. 2015, 15 (12): 103.
Higa S, Maesato A, Ishigaki S, Suenari K, Chen YJ, Chen SA: Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation. Card Electrophysiol Clin. 2021, 13 (1): 63-75.
Brodalko B: [Diabetes risk factors in the Regional Railway Hospital in Lublin, described on the basis of medical documentation]. Wiad Lek. 2000, 53 (5-6): 255-61.
Ìyàsímímọ́: ìtọ́jú ìlera
Oju opo wẹẹbu yii ni a pese fun eto-ẹkọ ati awọn idi alaye nikan ati pe ko ṣe agbekalẹ pese imọran iṣoogun tabi awọn iṣẹ ọjọgbọn.
A ò gbọ́dọ̀ lo ìsọfúnni tó wà nínú ìwé náà láti ṣe àyẹ̀wò tàbí láti wo àìsàn tàbí àìsàn kan wò, àwọn tó bá sì ń wá ìmọ̀ràn nípa ìṣègùn fúnra wọn gbọ́dọ̀ bá dókítà tó ní ìwé àṣẹ sọ̀rọ̀.
Jọwọ ṣe akiyesi nẹtiwọọki neural ti o ṣe agbejade awọn idahun si awọn ibeere, jẹ pataki ti ko tọ nigbati o ba de si akoonu nọmba. Fun apẹẹrẹ, nọmba awọn eniyan ti a ṣe ayẹwo pẹlu aisan kan pato.
Nigbagbogbo wa imọran ti dokita rẹ tabi olupese ilera ti o ni oye miiran nipa ipo iṣoogun kan. Maṣe gbagbe imọran iṣoogun ọjọgbọn tabi idaduro ni wiwa rẹ nitori nkan ti o ti ka lori oju opo wẹẹbu yii. Ti o ba ro pe o le ni pajawiri iṣoogun, pe 911 tabi lọ si yara pajawiri ti o sunmọ julọ lẹsẹkẹsẹ. Ko si ibatan dokita-aisan ti a ṣẹda nipasẹ oju opo wẹẹbu yii tabi lilo rẹ. Bẹni BioMedLib tabi awọn oṣiṣẹ rẹ, tabi ẹnikẹni ti o ṣe alabapin si oju opo wẹẹbu yii, ṣe eyikeyi awọn aṣoju, ṣalaye tabi tumọ, pẹlu ọwọ si alaye ti a pese nibi tabi lilo rẹ.
Ìyàsímímọ́: ẹ̀tọ́ ọmọnìyàn
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) n pese atunṣe fun awọn onihun aṣẹ-aṣẹ ti o gbagbọ pe ohun elo ti o han lori Intanẹẹti ṣe ilokulo awọn ẹtọ wọn labẹ ofin aṣẹ-aṣẹ AMẸRIKA.
Ti o ba gbagbọ ni igbagbọ to dara pe eyikeyi akoonu tabi ohun elo ti o wa ni asopọ pẹlu oju opo wẹẹbu wa tabi awọn iṣẹ ṣe ilokulo aṣẹ-aṣẹ rẹ, iwọ (tabi aṣoju rẹ) le firanṣẹ akiyesi kan si wa ti o beere pe a yọ akoonu tabi ohun elo naa kuro, tabi idilọwọ iraye si rẹ.
A gbọdọ firanṣẹ awọn iwifunni ni kikọ nipasẹ imeeli (wo abala "Ibaṣepọ" fun adirẹsi imeeli).
DMCA nilo pe akiyesi rẹ ti ilokulo aṣẹ-aṣẹ ti a fi ẹsun kan pẹlu alaye wọnyi: (1) apejuwe ti iṣẹ ti o ni aṣẹ-aṣẹ ti o jẹ koko-ọrọ ti ilokulo ti a fi ẹsun kan; (2) apejuwe ti akoonu ti a fi ẹsun kan ati alaye ti o to lati gba wa laaye lati wa akoonu naa; (3) alaye olubasọrọ fun ọ, pẹlu adirẹsi rẹ, nọmba foonu ati adirẹsi imeeli; (4) alaye nipasẹ rẹ pe o ni igbagbọ rere pe akoonu ni ọna ti o ni ẹsun ti ko ni aṣẹ nipasẹ eni aṣẹ-aṣẹ, tabi aṣoju rẹ, tabi nipasẹ iṣẹ ti ofin eyikeyi;
(5) ìpolongo kan láti ọ̀dọ̀ rẹ, tí o fìdí rẹ̀ múlẹ̀ lábẹ́ ìjìyà ẹ̀rí èké, pé ìsọfúnni tó wà nínú ìkéde náà tọ̀nà àti pé o ní àṣẹ láti mú kí àwọn ẹ̀tọ́ ọmọnìyàn tí wọ́n sọ pé wọ́n ti rú ṣẹ ṣẹ;
ati (6) ibuwọlu ti ara tabi itanna ti ẹni ti o ni aṣẹ tabi eniyan ti o ni aṣẹ lati ṣiṣẹ ni orukọ ẹni ti o ni aṣẹ.
Ti o ko ba ṣafikun gbogbo alaye ti o wa loke le ja si idaduro ti ṣiṣe ẹdun rẹ.
Ìfọ̀rọ̀wérọ̀
Jọwọ fi imeeli ranṣẹ si wa pẹlu eyikeyi ibeere / imọran.
What are the risk factors for diabetes?
There are several risk factors for diabetes, including:
1. Family history: Having a parent or sibling with diabetes increases your risk.
2. Age: The risk of type 2 diabetes increases as you get older, especially after age 45.
3. Weight: Being overweight or obese increases your risk.
4. Physical inactivity: Lack of exercise can increase your risk.
5. Race or ethnicity: Certain ethnic groups, such as African Americans, Hispanic Americans, Native Americans, and Asian Americans, have a higher risk of developing type 2 diabetes.
6. Gestational diabetes: Women who have had gestational diabetes during pregnancy are at higher risk of developing type 2 diabetes later in life.
7. Polycystic ovary syndrome: Women with this condition have a higher risk of developing type 2 diabetes.
8. Metabolic syndrome: This cluster of conditions, including high blood pressure, high cholesterol, and large waist circumference, increases the risk of type 2 diabetes.
9. Smoking: Smoking can increase insulin resistance, which can lead to type 2 diabetes.
10. Prediabetes: Having prediabetes, or higher than normal blood sugar levels, increases the risk of developing type 2 diabetes.
11. Low birth weight: Babies with low birth weight have a higher risk of developing type 2 diabetes later in life.
12. High blood pressure: Having high blood pressure increases the risk of developing type 2 diabetes.
13. Abnormal cholesterol and triglyceride levels: High levels of triglycerides and low levels of HDL (good) cholesterol increase the risk of type 2 diabetes.
14. Sleep apnea: People with sleep apnea have an increased risk of developing type 2 diabetes.
15. Stress: Chronic stress can increase the risk of developing type 2 diabetes.
16. Certain medications: Some medications, such as steroids and antipsychotics, can increase the risk of developing type 2 diabetes.
17. Inflammation: Chronic inflammation can increase the risk of developing type 2 diabetes.
18. Sedentary lifestyle: A sedentary lifestyle can increase the risk of developing type 2 diabetes.
19. High-fat, high-calorie diet: Consuming a diet high in unhealthy fats and calories can increase the risk of developing type 2 diabetes.
20. Alcohol consumption: Excessive alcohol consumption can increase the risk of developing type 2 diabetes.
21. Sleep deprivation: Inadequate sleep can increase the risk of developing type 2 diabetes.
22. Air pollution: Exposure to air pollution can increase the risk of developing type 2 diabetes.
23. Certain infections: Certain infections, such as hepatitis C, can increase the risk of developing type 2 diabetes.
24. High levels of homocysteine: High levels of homocysteine, an amino acid, can increase the risk of developing type 2 diabetes.
25. High levels of uric acid: High levels of uric acid, a waste product, can increase the risk of developing type 2 diabetes.
26. High levels of C-reactive protein: High levels of C-reactive protein, a marker of inflammation, can increase the risk of developing type 2 diabetes.
27. High levels of fibrinogen: High levels of fibrinogen, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.
28. High levels of PAI-1: High levels of PAI-1, a protein involved in blood clotting, can increase the risk of developing type 2 diabetes.
29. High levels of leptin: High levels of leptin, a hormone involved in appetite regulation, can increase the risk of developing type 2 diabetes.
30. High levels of resistin: High levels of resistin, a hormone involved in insulin resistance, can increase the risk of developing
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ní nǹkan bí
BioMedLib nlo awọn kọnputa adaṣe (awọn alugoridimu ẹkọ ẹrọ) lati ṣe agbejade awọn tọkọtaya ibeere ati idahun.
A bẹrẹ pẹlu awọn atẹjade biomedical miliọnu 35 ti PubMed/Medline. Pẹlupẹlu, awọn oju-iwe wẹẹbu ti RefinedWeb.
